Domains or Websites Registered and Owned by domain-management-d@gene.com

- bio-oncology.biz

Explore new research in cancer and learn how Genentech is transforming the way cancer is treated with innovative methods that target cancer and advance cancer research.

Not Applicable $ 8.95

- biooncology.biz

Explore new research in cancer and learn how Genentech is transforming the way cancer is treated with innovative methods that target cancer and advance cancer research.

Not Applicable $ 8.95

- dornasealfa.biz

Find information about cystic fibrosis and Pulmozyme, including how to manage your cystic fibrosis, your CF treatments, and options for financial support. INDICATION Pulmozyme (dornase alfa) is indicated for daily administration along with standard therapies for the management of cystic fibrosis (CF) patients to improv

Not Applicable $ 8.95

- cathflo.biz

Learn more about Cathflo® Activase® (alteplase), the only lytic FDA-approved for restoring CVAD function for patients with occluded catheters. Cathflo® Activase® (alteplase) is indicated for the restoration of function to central venous access devices (CVADs) as assessed by the ability to withdraw blood. Cathflo® Activ

Not Applicable $ 8.95

- alteplase.biz

Learn more about Cathflo® Activase® (alteplase), the only lytic FDA-approved for restoring CVAD function for patients with occluded catheters. Cathflo® Activase® (alteplase) is indicated for the restoration of function to central venous access devices (CVADs) as assessed by the ability to withdraw blood. Cathflo® Activ

Not Applicable $ 8.95

- activase.biz

Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset of stroke symptoms, and after exclusion of intracranial hemorrhage

Not Applicable $ 8.95

- eyeonvegf-a.biz

Find information and data for healthcare professionals about LUCENTIS® (ranibizumab injection) for the rapid and sustained improvement in vision for the treatment of wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. INDICATION LUCENTIS® (ranibizumab injection) is indicated for th

Not Applicable $ 8.95

- eyeonvegfa.biz

Find information and data for healthcare professionals about LUCENTIS® (ranibizumab injection) for the rapid and sustained improvement in vision for the treatment of wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. INDICATION LUCENTIS® (ranibizumab injection) is indicated for th

Not Applicable $ 8.95

- ionvegfa.biz

Discover Lucentis® (ranibizumab injection), a prescription medicine for the treatment of patients with wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO). Who is LUCENTIS for? LUCENTIS® (ranibizumab injection) is a prescription medicine

Not Applicable $ 8.95

- ionamd.biz

Breakthrough science. One moment, one day, one person at a time.

Not Applicable $ 8.95

- igeinfo.biz

Breakthrough science. One moment, one day, one person at a time.

Not Applicable $ 8.95

- her2connections.biz

Breakthrough science. One moment, one day, one person at a time.

Not Applicable $ 8.95

- her2connection.biz

Breakthrough science. One moment, one day, one person at a time.

Not Applicable $ 8.95

- genetechaccesssolutions.biz

Breakthrough science. One moment, one day, one person at a time.

Not Applicable $ 8.95

- genetechaccesssolution.biz

Breakthrough science. One moment, one day, one person at a time.

Not Applicable $ 8.95

- genentech-oncology.biz

Explore new research in cancer and learn how Genentech is transforming the way cancer is treated with innovative methods that target cancer and advance cancer research.

Not Applicable $ 8.95

- genentechoncology.biz

Explore new research in cancer and learn how Genentech is transforming the way cancer is treated with innovative methods that target cancer and advance cancer research.

Not Applicable $ 8.95

- genentechmm.biz

Learn why the site of careimpacts cost in oncologyA recent Milliman actuarial analysis from 40 million commercially insured lives explored cost differences for oncology care in hospital and community settings.See More 01

Not Applicable $ 8.95

- genentechmanagedcare.biz

Breakthrough science. One moment, one day, one person at a time.

Not Applicable $ 8.95

- genentech-biooncology.biz

Explore new research in cancer and learn how Genentech is transforming the way cancer is treated with innovative methods that target cancer and advance cancer research.

Not Applicable $ 8.95